Look-alike tubes kill patients regularly: Why is this still allowed?

Mistakes as simple — and avoidable — as confusing an IV with a feeding tube regularly injure and kill patients. And industry interests seem content to allow it to continue. Read more

Unlicensed ‘doc’ accused of $1m stem cell scam

Alfred Sapse faces 20 charges of wire and mail fraud for allegedly scamming 134 patients. Read more

New test for Alzheimer’s may be on the way

A new type of brain scan could give doctors their first chance to prove Alzheimer’s diagnoses while patients are alive. Read more

FDA blasts quality control at McNeil plant

More than 20 different problems with manufacturing and quality control processes at a major pharmaceutical plant were outlined in a report just released by the FDA. Read more

The other side of health reform: Increased wellness initiatives

Largely unnoticed in the run-up to the recent passage of the health reform law, President Obama also has his sights on improving programs focused on disease prevention and general wellness. Read more

80% of nitroglycerin scripts are filled with ‘unapproved’ pills

Several million cardiac patients have been taking pills never approved, or tested for safety, by the FDA. Read more

Senate report raises questions about FDA after-market review

A new report from the Senate Finance Committee highlights a potential conflict of interest within the FDA — and the safety of one of the world’s top-selling medications. Read more

Generics may not be as effective as we thought

The more research that’s done, the more some physicians worry that generic meds do work differently than the brand names they copy. Read more

Study: Docs confused about certain med uses

Turns out, doctors aren’t as up-to-date as they think they are on off-label uses of prescriptions — which could lead them to order treatments they wouldn’t otherwise. Read more

FDA looks to regulate Web marketing of medical products

We may soon have clearer guidelines as to what medical vendors can say when promoting their products via new social media outlets. Read more

« Previous PageNext Page »